Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desensitization Therapy in Patients Awaiting Heart Transplantation
NCT01769443Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jun 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in heart transplantation, sponsored by National Institute of Allergy and Infectious Diseases. Started Jun 2013; status: terminated.
02
Drugs
bortezomib
03
Conditions
heart transplantation
Beyond the preview
Go deeper on NCT01769443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01769443.